Homevideos Newshealthcare News

    Expect 25-26% EBITDA margins going forward, says Dr Lal Pathlabs

    videos | IST

    Expect 25-26% EBITDA margins going forward, says Dr Lal Pathlabs

    The third quarter numbers looked in-line for Dr Lal PathLabs with revenues up 11.3 percent year-on-year (YoY) to Rs 292.5 crore versus Rs 262.7 crore. The YoY EBITDA was up 16 percent and margins were up 22.43 percent. Profit increased by 27 percent.
    Elaborating on the numbers, Ved Goel, CFO of the company, said the revenue growth in the quarter was driven by volumes. For the quarter, volume growth was 12.1 percent and year to date it is 16 percent, he said, adding the revenue per patient has increased.
    The company has also been able to maintain its margins despite competition, said Goel, adding that going forward it expects normalised EBITDA margins to be in the range of 25-26 percent.
    Check out our in-depth Market Coverage, Business News & get real-time Stock Market Updates on CNBC-TV18. Also, Watch our channels CNBC-TV18, CNBC Awaaz and CNBC Bajar Live on-the-go!
    next story

      Most Read

      Market Movers

      View All
      CompanyPriceChng%Chng